β-Lactamase inhibitor peptides as the new strategies to overcome bacterial resistance

O N Silva1, O L Franco2, W F Porto3

  • 1S-Inova Biotech, Pós-graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil. osmar.silva@catolica.edu.

Insights

Bacterial resistance to antibiotics is a global crisis. New beta-lactamase inhibitor peptides offer a promising strategy against resistant Gram-negative bacteria, overcoming limitations of current inhibitors.

Area of Science:

  • Microbiology
  • Biotechnology
  • Drug Discovery

Background:

  • Antibiotic resistance in Gram-negative bacteria (e.g., Enterobacteriaceae, Pseudomonas, Acinetobacter) is a major global health threat.
  • Beta-lactamase production is a primary mechanism of resistance, hydrolyzing widely used beta-lactam antibiotics.
  • Existing beta-lactamase inhibitors are becoming less effective due to diverse beta-lactamase enzymes.

Purpose of the Study:

  • To review recent advancements in the design of beta-lactamase inhibitor peptides.
  • To explore the biotechnological potential of these novel peptide inhibitors.
  • To address the challenge of bacterial resistance to conventional treatments.

Main Methods:

  • Literature review focusing on recent findings in beta-lactamase inhibitor peptide design.
  • Analysis of studies detailing the development and characterization of these peptides.
  • Evaluation of biotechnological applications and potential.

Main Results:

  • Emerging beta-lactamase inhibitor peptides show promise in combating resistant Gram-negative bacteria.
  • These peptides offer an alternative strategy when conventional inhibitors fail.
  • Recent research highlights innovative designs and biotechnological applications.

Conclusions:

  • Beta-lactamase inhibitor peptides represent a significant development in antimicrobial strategies.
  • Their design and biotechnological potential are crucial for addressing the pandemic of antibiotic resistance.
  • Further research is needed to fully realize their therapeutic applications.

Related Concept Videos

Peptide Bonds02:43

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
82.9K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.7K
Bacterial Transformation01:33

Bacterial Transformation

In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.9K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
210
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K